» Articles » PMID: 24717534

Controlling the Structural and Functional Anisotropy of Engineered Cardiac Tissues

Overview
Journal Biofabrication
Date 2014 Apr 11
PMID 24717534
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to control the degree of structural and functional anisotropy in 3D engineered cardiac tissues would have high utility for both in vitro studies of cardiac muscle physiology and pathology as well as potential tissue engineering therapies for myocardial infarction. Here, we applied a high aspect ratio soft lithography technique to generate network-like tissue patches seeded with neonatal rat cardiomyocytes. Fabricating longer elliptical pores within the patch networks increased the overall cardiomyocyte and extracellular matrix alignment within the patch. Improved uniformity of cell and matrix alignment yielded an increase in anisotropy of action potential propagation and faster longitudinal conduction velocity (LCV). Cardiac tissue patches with a higher degree of cardiomyocyte alignment and electrical anisotropy also demonstrated greater isometric twitch forces. After two weeks of culture, specific measures of electrical and contractile function (LCV = 26.8 ± 0.8 cm s(-1), specific twitch force = 8.9 ± 1.1 mN mm(-2) for the longest pores studied) were comparable to those of neonatal rat myocardium. We have thus described methodology for engineering of highly functional 3D engineered cardiac tissues with controllable degree of anisotropy.

Citing Articles

Cardiomyocytes in Hypoxia: Cellular Responses and Implications for Cell-Based Cardiac Regenerative Therapies.

Dwyer K, Snyder C, Coulombe K Bioengineering (Basel). 2025; 12(2).

PMID: 40001674 PMC: 11851968. DOI: 10.3390/bioengineering12020154.


Engineered Cardiac Tissues as a Platform for CRISPR-Based Mitogen Discovery.

DeLuca S, Strash N, Chen Y, Patsy M, Myers A, Tejeda L Adv Healthc Mater. 2024; 14(1):e2402201.

PMID: 39508305 PMC: 11695184. DOI: 10.1002/adhm.202402201.


Multidirectional Filamented Light Biofabrication Creates Aligned and Contractile Cardiac Tissues.

Jones L, Filippi M, Michelis M, Balciunaite A, Yasa O, Aviel G Adv Sci (Weinh). 2024; 11(47):e2404509.

PMID: 39373330 PMC: 11653608. DOI: 10.1002/advs.202404509.


Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning.

Snyder C, Dwyer K, Coulombe K Int J Mol Sci. 2024; 25(17).

PMID: 39273573 PMC: 11395605. DOI: 10.3390/ijms25179627.


Emerging technologies for cardiac tissue engineering and artificial hearts.

Sun L, Wang Y, Xu D, Zhao Y Smart Med. 2024; 2(1):e20220040.

PMID: 39188557 PMC: 11235648. DOI: 10.1002/SMMD.20220040.


References
1.
Terracio L, Miller B, Borg T . Effects of cyclic mechanical stimulation of the cellular components of the heart: in vitro. In Vitro Cell Dev Biol. 1988; 24(1):53-8. DOI: 10.1007/BF02623815. View

2.
van Kempen M, Fromaget C, Gros D, Moorman A, Lamers W . Spatial distribution of connexin43, the major cardiac gap junction protein, in the developing and adult rat heart. Circ Res. 1991; 68(6):1638-51. DOI: 10.1161/01.res.68.6.1638. View

3.
SPACH M, BOINEAU J . Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing Clin Electrophysiol. 1997; 20(2 Pt 2):397-413. DOI: 10.1111/j.1540-8159.1997.tb06199.x. View

4.
Bian W, Juhas M, Pfeiler T, Bursac N . Local tissue geometry determines contractile force generation of engineered muscle networks. Tissue Eng Part A. 2011; 18(9-10):957-67. PMC: 3338113. DOI: 10.1089/ten.TEA.2011.0313. View

5.
Donndorf P, Strauer B, Haverich A, Steinhoff G . Stem cell therapy for the treatment of acute myocardial infarction and chronic ischemic heart disease. Curr Pharm Biotechnol. 2012; 14(1):12-9. View